Founded in 2010, Hainice has forged a 15-year path of industrial development. Rooted firmly in the physical industry of diabetes medical devices, the brand takes quality, innovation and public benefit as three core pillars, growing steadily into a trusted local medical device brand in China with comprehensive industrial capabilities and wide public recognition. Over 16 years of sound development, it has witnessed the industry shift of domestic chronic disease monitoring devices from import reliance to independent domestic control.

Rejecting short-term speculative strategies throughout its growth, Hainice has steadily strengthened its industrial foundation in phases. In the initial stage, it built basic production and testing workshops and established standardized quality control procedures. In the medium term, a dedicated R&D team was formed to pursue independent technological breakthroughs, securing a number of intellectual property rights. In the long run, the enterprise has expanded offline sales networks nationwide, built an integrated online and after-sales service system, and optimized its supply chain to offer affordable pricing, addressing the public’s three major concerns regarding domestic devices: stability, service accessibility and usage costs.

Faced with huge domestic demand for home-based diabetes monitoring, Hainice consistently caters to Chinese users’ habits and people’s consumption capacity. It keeps simplifying device operation, stabilizing the supply of consumables and reasonably regulating end prices to meet the needs of users in cities, towns and rural areas alike. The enterprise strictly complies with laws and regulations governing medical devices in all operations. All links including production, testing and promotion operate in full compliance. It delivers authentic product information and upholds the code of conduct for the healthcare industry.

Down-to-earth for fifteen years, Hainice has shunned explosive traffic marketing. It has built its reputation through solid industrial accumulation. With independent technologies, standardized quality and all-round accessible services, the brand bridges public trust in domestic blood glucose monitoring devices. Going forward, Hainice will stay committed to its original aspiration: quality-oriented development, technological innovation and technology for public well-being. It will continue to deepen its presence in diabetes monitoring, upgrade products and services, and fulfill its civic responsibilities as a local medical device enterprise.